Steve Barry Biography

Dr. Stephen Barry is the president of Alnis and leads the development of Alnis' nanotechnology products.  He conceived of the MagNaGel technology platform and is the Principal Investigator of Alnis' contract with the National Cancer Institute that supports the development of MagNaGel nanoparticles.

Before joining Alnis, Dr. Barry worked in technical and business development roles at ZMS in fabricating polymers for electronic and microelectronic applications; this technology was sold to the Dow Chemical Company.

Prior to this he worked in technical development and product manager capacities at Soane Technologies, an advanced materials-based start-up that was eventually split into 2C Optics, now Rodenstock USA, and ACLARA, now Monogram.

Dr. Barry received a bachelor of science degree in chemical engineering from the University of Texas and his doctorate in chemical engineering from UC-Berkeley.